Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Neu

Showing results (141-150 of 505) with videos related to

Pageof 51
Sort By:
Journal of Clinical Pharmacology|February 1, 1988
Macrolides: problems and promisesH C Neu
The American Journal of Medicine|September 12, 1991
Clinical microbiology of azithromycinH C Neu
Current Problems in Surgery|June 1, 1973
Antimicrobial agents--mechanisms of action and clinical usageH C Neu
Geriatrics|November 1, 1985
Use of the newer agents for antibiotic-resistant infection: Harold C. Neu, MD. Interview by Richard L. PeckH C Neu
Annual Review of Pharmacology and Toxicology|January 1, 1982
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibioticsH C Neu
Antimicrobial Agents and Chemotherapy|January 1, 1983
beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanateH C Neu
Reviews of Infectious Diseases|March 1, 1983
The emergence of bacterial resistance and its influence on empiric therapyH C Neu
Infection|January 1, 1983
What do beta-lactamases mean for clinical efficacy?H C Neu
Annals of the New York Academy of Sciences|January 1, 1988
A perspective on therapy of Lyme infectionH C Neu
The Pediatric Infectious Disease Journal|July 1, 1995
Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programsH C Neu
Pageof 51

Showing results (141-150 of 505) with videos related to

Sort By:
Pageof 51
Journal of Clinical Pharmacology|February 1, 1988
Macrolides: problems and promisesH C Neu
The American Journal of Medicine|September 12, 1991
Clinical microbiology of azithromycinH C Neu
Current Problems in Surgery|June 1, 1973
Antimicrobial agents--mechanisms of action and clinical usageH C Neu
Geriatrics|November 1, 1985
Use of the newer agents for antibiotic-resistant infection: Harold C. Neu, MD. Interview by Richard L. PeckH C Neu
Annual Review of Pharmacology and Toxicology|January 1, 1982
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibioticsH C Neu
Antimicrobial Agents and Chemotherapy|January 1, 1983
beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanateH C Neu
Reviews of Infectious Diseases|March 1, 1983
The emergence of bacterial resistance and its influence on empiric therapyH C Neu
Infection|January 1, 1983
What do beta-lactamases mean for clinical efficacy?H C Neu
Annals of the New York Academy of Sciences|January 1, 1988
A perspective on therapy of Lyme infectionH C Neu
The Pediatric Infectious Disease Journal|July 1, 1995
Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programsH C Neu
Pageof 51